Abstract Bladder cancer (BLCA). ranking as the tenth most prevalent malignancy globally. imposes a substantial public health and socio-economic challenge. Despite ongoing efforts by urologists to identify novel molecular subtypes and treatment paradigms. https://www.foldlyers.shop/product-category/toggle-switches/
MFAP3L predicts tumor microenvironment status, molecular subtypes and clinical benefit in patients with bladder cancer
Internet - 44 minutes ago hiqrzrn911x0mWeb Directory Categories
Web Directory Search
New Site Listings